广发证券发布研究报告称，维持华润医疗（01515）“买入”评级，持续推进医院集团化运营、精细化管理，预计利润率趋于提升，预计25~26年归母净利润同比增长7%左右，合理价值5.98港元。24年受两年医保结算差额影响，预计24年医院业务收入略降，预计25~26年医保结算差额影响减小，预计医院业务收入同比增长4~5%。持续降本增效应对两年医保结算差额的影响，预计24年内生业绩稳健增长，预计24年归母...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.